NKT cells in mucosal immunity

Mucosal Immunology

Volumn 2, Issue 5, 2009, Pages 393-402

  Middendorp, S ^a   Nieuwenhuis, E E S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 22; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DELTA NATURAL KILLER T CELL; DENDRITIC CELL; ENTERITIS; GAMMA NATURAL KILLER T CELL; HUMAN; INTESTINE CELL; LIGAND BINDING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MUCOSAL IMMUNITY; NATURAL KILLER T CELL; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE; T LYMPHOCYTE SUBPOPULATION;

EID: 69249113500     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.99     Document Type: Review

References (145)

1. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
2. van Dieren, J.M. et al. Roles of CD1d-restricted NKT cells in the intestine. Inflamm. Bowel Dis. 13, 1146-1152 (2007).
3. Wingender, G. & Kronenberg, M. Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1-8 (2008).
4. Zeissig, S., Kaser, A., Dougan, S. K., Nieuwenhuis, E. E. & Blumberg, R.S. Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1101-1105 (2007).
5. Brigl, M. & Brenner, M. B. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
6. Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J. & Van Kaer, L. NKT cells: What's in a name? Nat. Rev. Immunol. 4, 231-237 (2004).
7. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895-1903 (2000).
8. Matsuda, J.L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
9. Treiner, E. et al. Selection of evolutionarily conserved mucosalassociated invariant T cells by MR1. Nature 422, 164-169 (2003).
10. Chiu, Y.H. et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189, 103-110 (1999).
11. Jahng, A. et al. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199, 947-957 (2004).
12. Fuss, I.J. et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113, 1490-1497 (2004).
13. Arrenberg, P., Halder, R. & Kumar, V. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J. Cell. Physiol. 218, 246-250 (2009).
14. Halder, R.C., Aguilera, C., Maricic, I. & Kumar, V. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J. Clin. Invest. 117, 2302-2312 (2007).
15. Lees, R.K., Ferrero, I. & MacDonald, H.R. Tissue-specific segregation of TCRgamma delta+ NKT cells according to phenotype TCR repertoire and activation status: Parallels with TCR alphabeta+NKT cells. Eur. J. Immunol. 31, 2901-2909 (2001).
16. Matsuda, J.L., Mallevaey, T., Scott-Browne, J. & Gapin, L. CD1d-restricted iNKT cells, the "Swiss-Army knife" of the immune system. Curr. Opin. Immunol. 20, 358-368 (2008).
17. Griewank, K. et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27, 751-762 (2007).
18. Kovalovsky, D. et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9, 1055-1064 (2008).
19. Savage, A.K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391-403 (2008).
20. Lazarevic, V. et al. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10, 306-313 (2009).
21. Mycko, M.P. et al. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development. J. Immunol. 182, 4641-4648 (2009).
22. Doisne, J.M. et al. iNKT cell development is orchestrated by different branches of TGF-beta signaling. J. Exp. Med. 206, 1365-1378 (2009).
23. Astrakhan, A., Ochs, H.D. & Rawlings, D.J. Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J. Immunol. 182, 7370-7380 (2009).
24. Martin, E. et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 7, e54 (2009).
25. Raberger, J. et al. The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells. Proc. Natl Acad. Sci. USA 105, 17919-17924 (2008).
26. Godfrey, D. I. & Berzins, S. P. Control points in NKT-cell development. Nat. Rev. Immunol. 7, 505-518 (2007).
27. Bannai, M. et al. Abundance of unconventional CD8(+) natural killer T cells in the large intestine. Eur. J. Immunol. 31, 3361-3369 (2001).
28. Ishimoto, Y. et al. Age-dependent variation in the proportion and number of intestinal lymphocyte subsets, especially natural killer T cells, doublepositive CD4+ CD8+ cells and B220+ T cells, in mice. Immunology 113, 371-377 (2004).
29. Iiai, T. et al. CD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liver. Clin. Exp. Immunol. 129, 92-98 (2002).
30. O'Keeffe, J. et al. Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer. Eur. J. Immunol. 34, 2110-2119 (2004).
31. Lee, P.T. et al. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110, 793-800 (2002).
32. Hansen, T.H., Huang, S., Arnold, P.L. & Fremont, D.H. Patterns of nonclassical MHC antigen presentation. Nat. Immunol. 8, 563-568 (2007).
33. Tilloy, F. et al. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J. Exp. Med. 189, 1907-1921 (1999).
34. Croxford, J.L., Miyake, S., Huang, Y.Y., Shimamura, M. & Yamamura, T. Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat. Immunol. 7, 987-994 (2006).
35. Kawachi, I., Maldonado, J., Strader, C. & Gilfillan, S. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J. Immunol. 176, 1618-1627 (2006).
36. Carding, S.R. & Egan, P.J. Gammadelta T cells: Functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336-345 (2002).
37. Felices, M., Yin, C.C., Kosaka, Y., Kang, J. & Berg, L.J. Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivo. Proc. Natl Acad. Sci. USA 106, 8308-8313 (2009).
38. Berg, L.J. Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development. Nat. Rev. Immunol. 7, 479-485 (2007).
39. Ismail, A.S., Behrendt, C.L. & Hooper, L.V. Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J. Immunol. 182, 3047-3054 (2009).
40. Hoffmann, J.C. et al. Gammadelta T lymphocytes: A new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis. Int. J. Colorectal Dis. 23, 909-920 (2008).
41. Zeng, Z. et al. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345 (1997).
42. Balk, S.P. et al. Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265 259-262 (1994).
43. Bleicher, P.A. et al. Expression of murine CD1 on gastrointestinal epithelium. Science 250, 679-682 (1990).
44. Blumberg, R.S. et al. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J. Immunol. 147, 2518-2524 (1991).
45. Panja, A., Blumberg, R.S., Balk, S.P. & Mayer, L. CD1d is involved in T cell-intestinal epithelial cell interactions. J. Exp. Med. 178 1115-1119 (1993).
46. van de Wal, Y. et al. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 124, 1420-1431 (2003).
47. Kita, H. et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123, 1031-1043 (2002).
48. Metelitsa, L.S., Weinberg, K.I., Emanuel, P.D. & Seeger, R.C. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia 17, 1068-1077 (2003).
49. Colgan, S.P., Hershberg, R.M., Furuta, G.T. & Blumberg, R.S. Ligation of intestinal epithelial CD1d induces bioactive IL-10: Critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl Acad. Sci. USA 96, 13938-13943 (1999).
50. Brutkiewicz, R.R. CD1d ligands: The good, the bad, and the ugly. J. Immunol. 177, 769-775 (2006).
51. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
52. Burdin, N. et al. Selective ability of mouse CD1 to present glycolipids: Alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J. Immunol. 161, 3271-3281 (1998).
53. Sidobre, S. et al. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169, 1340-1348 (2002).
54. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
55. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
56. Sriram, V., Du, W., Gervay-Hague, J. & Brutkiewicz, R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35, 1692-1701 (2005).
57. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7, 978-986 (2006).
58. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl Acad. Sci. USA 101, 10685-10690 (2004).
59. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
60. Porubsky, S. et al. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl Acad. Sci. USA 104, 5977-5982 (2007).
61. Speak, A. O. et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl Acad. Sci. USA 104, 5971-5976 (2007).
62. Kronenberg, M. & Gapin, L. Natural killer T cells: Know thyself. Proc. Natl Acad. Sci. USA 104, 5713-5714 (2007).
63. Salio, M. et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc. Natl Acad. Sci. USA 104, 20490-20495 (2007).
64. Askenase, P.W. et al. TLR-dependent IL-4 production by invariant Valpha14+Jalpha18+ NKT cells to initiate contact sensitivity in vivo. J. Immunol. 175, 6390-6401 (2005).
65. Shimamura, M. et al. Modulation of Valpha19 NKT cell immune responses by alpha-mannosyl ceramide derivatives consisting of a series of modified sphingosines. Eur. J. Immunol. 37, 1836-1844 (2007).
66. Huang, S. et al. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J. Exp. Med. 205, 1201-1211 (2008).
67. Nieuwenhuis, E.E. et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8, 588-593 (2002).
68. Nieuwenhuis, E.E. et al. Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J. Clin. Invest. 119, 1241-1250 (2009).
69. Nieuwenhuis, E.E. et al. CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp. Dermatol. 14 250-258 (2005).
70. Godfrey, D.I. & Kronenberg, M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388 (2004).
71. Crowe, N.Y. et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202, 1279-1288 (2005).
72. Smyth, M.J. & Godfrey, D.I. NKT cells and tumor immunity - a double-edged sword. Nat. Immunol. 1, 459-460 (2000).
73. Wilson, S.B. & Delovitch, T.L. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3 211-222 (2003).
74. Gumperz, J.E., Miyake, S., Yamamura, T. & Brenner, M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
75. Liang, S.C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
76. Goto, M. et al. Murine NKT cells produce Th17 cytokine interleukin-22. Cell. Immunol. 254, 81-84 (2009).
77. Michel, M.L. et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl Acad. Sci. USA 105, 19845-19850 (2008).
78. Coquet, J.M. et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1 - NKT cell population. Proc. Natl Acad. Sci. USA 105, 11287-11292 (2008).
79. Rachitskaya, A.V. et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180, 5167-5171 (2008).
80. Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (2003).
81. Nielsen, O.H., Kirman, I., Rudiger, N., Hendel, J. & Vainer, B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38, 180-185 (2003).
82. Hue, S. et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203, 2473-2483 (2006).
83. Kullberg, M.C. et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203 2485-2494 (2006).
84. Arisawa, T. et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J. Clin. Immunol. 28, 44-49 (2008).
85. Dumoutier, L., Louahed, J. & Renauld, J. C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164, 1814-1819 (2000).
86. Ouyang, W., Kolls, J.K. & Zheng, Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467 (2008).
87. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 648-651 (2007).
88. Zenewicz, L.A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
89. Boniface, K. et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174, 3695-3702 (2005).
90. Sa, S.M. et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 178, 2229-2240 (2007).
91. Wolk, K. et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis. Eur. J. Immunol. 36, 1309-1323 (2006).
92. Maloy, K.J. The interleukin-23/interleukin-17 axis in intestinal inflammation. J. Intern. Med. 263, 584-590 (2008).
93. Mayer, L. & Shao, L. Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4, 407-419 (2004).
94. Kim, H.J., Hwang, S.J., Kim, B.K., Jung, K.C. & Chung, D.H. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 118, 101-111 (2006).
95. Vincent, M. S. et al. CD1-dependent dendritic cell instruction. Nat. Immunol. 3, 1163-1168 (2002).
96. Roelofs-Haarhuis, K., Wu, X. & Gleichmann, E. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173, 1043-1050 (2004).
97. Ishimitsu, R., Yajima, T., Nishimura, H., Kawauchi, H. & Yoshikai, Y. NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E. Eur. J. Immunol. 33, 183-193 (2003).
98. Chung, Y., Chang, W. S., Kim, S. & Kang, C. Y. NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation. Eur. J. Immunol. 34, 2471-2479 (2004).
99. Courtney, A.N. et al. Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens. Vaccine 27, 3335-3341 (2009).
100. Lindqvist, M., Persson, J., Thorn, K. & Harandi, A. M. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection. J. Immunol. 182, 6435-6443 (2009).
101. Chang, J.H. et al. Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance. Eur. J. Immunol. 38, 2727-2739 (2008).
102. Chirdo, F.G., Millington, O.R., Beacock-Sharp, H. & Mowat, A.M. Immunomodulatory dendritic cells in intestinal lamina propria. Eur. J. Immunol. 35, 1831-1840 (2005).
103. Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S. & Strober, W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17, 629-638 (2002).
104. Nieuwenhuis, E.E. et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl Acad. Sci. USA 99, 16951-16956 (2002).
105. Saubermann, L.J. et al. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119, 119-128 (2000).
106. Ueno, Y. et al. Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm. Bowel Dis. 11, 35-41 (2005).
107. Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2, 557-568 (2002).
108. Laouar, A. et al. CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat. Immunol. 6, 698-706 (2005).
109. Niess, J.H. et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254-258 (2005).
110. Jang, M.H. et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 176, 803-810 (2006).
111. Johansson-Lindbom, B. et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp Med. 202, 1063-1073 (2005).
112. Worbs, T. et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203, 519-527 (2006).
113. Nagarajan, N.A. & Kronenberg, M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178, 2706-2713 (2007).
114. Van Kaer, L. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19, 354-364 (2007).
115. Germain, R.N. An innately interesting decade of research in immunology. Nat. Med. 10, 1307-1320 (2004).
116. Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237 (2003).
117. Wu, D. et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl Acad. Sci. USA 102, 1351-1356 (2005).
118. Belperron, A.A., Dailey, C.M. & Bockenstedt, L.K. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J. Immunol. 174 5681-5686 (2005).
119. Galli, G. et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197, 1051-1057 (2003).
120. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219-230 (2002).
121. Velazquez, P. et al. Villous B cells of the small intestine are specialized for invariant NK T cell dependence. J. Immunol. 180 4629-4638 (2008).
122. Park, S.H., Benlagha, K., Lee, D., Balish, E. & Bendelac, A. Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice. Eur. J. Immunol. 30, 620-625 (2000).
123. Hooper, L.V. et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884 (2001).
124. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8, 411-420 (2008).
125. Macpherson, A.J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662-1665 (2004).
126. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2 675-680 (2001).
127. Ouellette, A.J. Paneth cell alpha-defensin synthesis and function. Curr. Top. Microbiol. Immunol. 306, 1-25 (2006).
128. Ouellette, A.J. Paneth cell alpha-defensins: Peptide mediators of innate immunity in the small intestine. Springer Semin. Immunopathol. 27, 133-146 (2005).
129. Salzman, N.H., Underwood, M.A. & Bevins, C.L. Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa. Semin. Immunol. 19, 70-83 (2007).
130. Lacasse, J. & Martin, L.H. Detection of CD1 mRNA in Paneth cells of the mouse intestine by in situ hybridization. J. Histochem. Cytochem. 40, 1527-1534 (1992).
131. Balk, S.P. et al. Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science 253, 1411-1415 (1991).
132. Perera, L. et al. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm. Bowel Dis. 13, 298-307 (2007).
133. Lee, P.T., Benlagha, K., Teyton, L. & Bendelac, A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195, 637-641 (2002).
134. Gansert, J.L. et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol. 170, 3154-3161 (2003).
135. Barral, P. et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl Acad. Sci. USA 105 8345-8350 (2008).
136. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007).
137. Kaser, A. et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134, 743-756 (2008).
138. Marks, D.J. et al. Defective acute inflammation in Crohn's disease: A clinical investigation. Lancet 367, 668-678 (2006).
139. Rioux, J.D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
140. Wakao, H. et al. A novel mouse model for invariant NKT cell study. J. Immunol. 179, 3888-3895 (2007).
141. Taniguchi, M. et al. Essential requirement of an invariant V alpha 14T cell antigen receptor expression in the development of natural killer T cells. Proc. Natl Acad. Sci. USA 93, 11025-11028 (1996).
142. Capone, M. et al. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1 - T cells in transgenic mice. J. Immunol. 170, 2390-2398 (2003).
143. Cui, J. et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626 (1997).
144. Chen, Y.H., Chiu, N.M., Mandal, M., Wang, N. & Wang, C. R. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6, 459-467 (1997).
145. Smiley, S.T., Kaplan, M.H. & Grusby, M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977-979 (1997).